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Available online 21 March 2014We present a workflow using an ETD-optimised version of Mascot Percolator and a modified
version of SLoMo (turbo-SLoMo) for analysis of phosphoproteomic data. We have benchmarked
this against several database searching algorithms and phosphorylation site localisation tools
and show that it offers highly sensitive and confident phosphopeptide identification and site
assignmentwith PSM-level statistics, enabling rigorous comparison of data acquisitionmethods.
We analysed the Plasmodium falciparum schizont phosphoproteome using for the first time, a
data-dependent neutral loss-triggered-ETD (DDNL) strategy and a conventional decision-tree
method.At aposterior error probability threshold of 0.01, similar numbers of PSMswere identified
using both methods with a 73% overlap in phosphopeptide identifications. The false discovery
rate associatedwith spectral pairswhereDDNLCID/ETD identified the samephosphopeptidewas
<1%. 72% of phosphorylation site assignments using turbo-SLoMo without any score filtering,
were identical and 99.8% of these cases are associated with a false localisation rate of <5%. We
show that DDNL acquisition is a useful approach for phosphoproteomics and results in an
increased confidence in phosphopeptide identificationwithout compromising sensitivity or duty
cycle. Furthermore, the combination of Mascot Percolator and turbo-SLoMo represents a robust
workflow for phosphoproteomic data analysis using CID and ETD fragmentation.
Biological significance
Protein phosphorylation is a ubiquitous post-translational modification that regulates protein
function. Mass spectrometry-based approaches have revolutionised its analysis on a large-scale
but phosphorylation sites are often identified by single phosphopeptides and therefore require
more rigorousdata analysis to unsure that sites are identifiedwithhigh confidence for follow-up
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2 J O U R N A L O F P R O T E O M I C S 1 0 3 ( 2 0 1 4 ) 1 – 1 4phosphoproteomic experiments can be enhanced by the use of multiple complementary
fragmentation methods. Here we have benchmarked a data analysis pipeline for analysis of
phosphoproteomic data generatedusingCIDandETD fragmentation andused it to demonstrate
the utility of a data-dependent neutral loss triggered ETD fragmentation strategy for high
confidence phosphopeptide identification and phosphorylation site localisation.
Crown Copyright © 2014 Published by Elsevier B.V. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/3.0/).1. Introduction
Protein phosphorylation is the most studied post-translational
modifications and it regulatesmost biological processes. A large
proportion of genomes encode proteins that regulate protein
phosphorylation (kinases and phosphatases) as well as many
classes of protein domains that recognize it as a regulated
epitope. The analysis of protein phosphorylation has been
transformed in recent years with the development of methods
to enrich phosphopeptides from complex mixtures [1–5], soft
peptide fragmentation techniques such as electron transfer
dissociation [6], as well as advances in the sensitivity and
specificity of mass spectrometry instrumentation. Protein phos-
phorylation was the first PTM studied on a proteome scale and
since then protein acetylation [7], ubiquitination [8] and
O-GlcNAcylation [9], amongst othershavebenefitted fromsimilar
technological developments.
CID fragmentation is generally the method of choice for
peptide fragmentation and its implementation in ion trap and
Q-ToF type devices allows rapid and sensitive peptide identifi-
cation. Recent generations of mass spectrometers have also
been enabled with various configurations of ETD sources [6,10]
enabling a type of peptide fragmentation that is considered
complementary to CID [11]. CID fragmentation of peptides
bearing labile modifications often result in spectra that are
dominated by large neutral loss peaks [12] with compromised
sequence information compared to spectra from non-modified
counterparts [13]. ETD however, preserves labile side chain
modifications such as phosphorylation and O-GlcNAcylation
and has attracted much attention for the analysis of PTMs [14].
Generally, CID fragmentation is more suited to lower charge
states and higher precursor mass, whilst ETD is better suited to
higher charge but lower m/z precursor ions [15]. The duty cycle
of ETD is currently slower thanCID due to longer reaction times,
70–100 ms for ETD versus 10–30 ms for CID. Therefore, the
combined/targeted use of these complementary methods in
the same experiment can improve peptide and protein
identification rates and reduce the amount of sample needed
and total acquisition time [15]. Recently, it has been reported
that through optimisation of ETD reaction parameters and
the use of alternative reagents, ETD fragmentation can be
performed at optimal efficiency in time scales similar to CID
[16]. This will further enhance the use of combined alterna-
tive fragmentation methods as duty cycle constraints are
lessened.
Analysis of data acquired using alternative fragmentation
methods and from peptides bearing post-translational modifi-
cations is not straightforward for a number of reasons.
Alternative fragmentation methods can require additional
processing and an increased number of fragment ion types to
be considered. This leads to a higher computational overheadwith an increased risk of false positivematches. Themajority of
database searching algorithms were built to analyse data from
CID spectra and over the years as alternative fragmentation
methods have been developed, they have been modified to
allow for the different ion series produced by these methods.
This integration of different fragmentation types has also
been implemented in post-search algorithms such as Mascot
Percolator [17,18] and Protein Prospector [19], allowing scoring
and accurate FDR calculations to be determined in a single
pipeline regardless of fragmentation type.
For modified peptides, the search space is inflated due to
additional variable modifications and an increased number of
missed cleavages caused by phosphorylation sites adjacent to
enzymatic cleavage sites [20]. Furthermore, phosphopeptide
spectra tend to have added complexity, especially from CID,
where neutral loss peaks are present. This can cause a
substantial decrease in informative fragment ions and
this in turn affects peptide spectrum match (PSM) scoring;
modified spectra score lower than their unmodified counter-
parts. Again, post-search tools such as Mascot Percolator can
help to boost the scores of these spectra; however this is still
reliant on the initial search being able to correctly assign the
peptide sequence. Finally, localisation of phosphorylation
sites using fragmentation information is not straightforward
[21]. Sites can only be assigned if fragment ions surrounding
potential phosphorylation sites are present; often this is
further complicated by multiple phosphorylatable residues
being adjacent and single peptides having multiple modifica-
tions. There are various tools to help evaluate modification
site assignment including Mascot Delta Score [22], Ascore [23],
PhosphoRS [24] and SloMo [25] amongst others (see [21] for
detailed review). These tools have been benchmarked using
data from phosphopeptide standards and it is assumed that
false localisation rates are consistent between standard and
biological datasets [21].
We set out to explore workflows for large scale phos-
phoproteomics using combinations of CID and ETD fragmenta-
tion and evaluation of a single data analysis pipeline comprising
of Mascot Percolator and a modified version of the site
localisation tool, SLoMo (turbo-SLoMo). We investigate the
performance of two types of targeted CID and ETD analysis;
decision tree (DT) and data-dependent neutral loss triggered ETD
(DDNL), for the analysis of the Plasmodium falciparum schizont
phosphoproteome. We explore the utility of CID/ETD spectral
pairs from DDNL experiments for high confidence phospho-
peptide identification and phosphorylation site localisation,
exploiting self-validating spectral pairs to assess the perfor-
mance of the data analysis workflow. Finally, we use the
combined Mascot Percolator and turbo-SLoMo data analysis
workflow to generate a high confidence P. falciparum schizont
phosphoproteome.
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2.1. Preparation of parasites
P. falciparum strain 3D7 was cultured in 2.5–5% O+ human
erythrocytes with 0.5% Albumax II in custom-made RPMI
media (Invitrogen) and parasites were collected by saponin
lysis, an approach that removes the vast majority of
erythrocyte material. Briefly, infected erythrocytes were
pelleted and re-suspended in 5–10 ml of 0.1% Saponin lysis
buffer (0.1% Saponin in PBS) and incubated at room temper-
ature for 5 min before being centrifuged at 3200 ×g for
10 min. After centrifugation, the supernatant was discarded
and the parasite pellet was washed with 0.1% Saponin lysis
buffer and centrifuged again at 3200 ×g for 10 min.Washeswith
0.1% Saponin lysis buffer were repeated until supernatants
were completely clear.
2.2. Protein extraction, digestion and clean up
Parasite pellets were re-suspended in extraction buffer (4%
SDS, 0.1 M DTT, 0.1 M Tris pH 8, 0.5 mM PMSF, 2 μg/ml
Aprotinin/Leupeptin, 20 μM ZnCl and 25 mM Sodium fluoride),
homogenised in a 2 ml dounce homogeniser with 25 strokes
and DNA was sheared by passing the lysate through a fine
gauge needle. The sample was heated for 5 min @ 97 °C and
insoluble material was pelleted by centrifugation at 14,000 rpm
for 10 min. The insoluble pellet was further extracted by
addition of urea (once cooled to room temperature) to a
final concentration of 8 M. Homogenisation and centrifuga-
tion steps were repeated and supernatants containing
solubilized protein from both extractions were pooled and
applied to a pre-washed Amicom-15 centrifugal filter unit
(30 kD MWCO) (Millipore). The protein sample (4 mg) was
processed according to the FASP procedure [26,27] in which
SDS was removed by buffer exchange with urea and cysteine
alkylation was performed in situ with iodoacetamide and
proteins were digested with Trypsin Gold (Promega) for 4 h at
37 °C at an enzyme substrate ratio of 1:20 with a urea
concentration of 1.8 M and 100 mM ammonium bicarbonate.
Peptides were collected by centrifugation and addition of
100 mM ammonium bicarbonate to the upper chamber of the
unit and further centrifugation. Collected peptides were
adjusted to a 0.4% TFA and desalted using a Sep-Pak® Light
C18 cartridge (Waters) and dried down using a SpeedVac
(Thermo Scientific).
2.3. IMAC purification
IMAC purifications were performed as described [28], with the
following modifications. Peptides were re-suspended in IMAC
loading buffer (50% acetonitrile, 0.1% TFA) and incubated with
pre-equilibrated Phos-Select beads (Sigma) for 1 h at room
temperature. The beads were then transferred to a TopTip
(Glygen) and washed once with IMAC loading buffer, 1% acetic
acid and then water. Phosphopeptides were eluted with 100 μl
ammonia water pH 11 and acidified using formic acid.
Phosphopeptides from two IMAC purifications were pooled
and split into 6 aliquots for LC–MS/MS analysis.2.4. LC–MS/MS analysis
Phosphopeptide samples were analysed online using an
Ultimate 3000 nano/Capillary LC System (Dionex) coupled to
an LTQ Orbitrap Velos hybrid mass spectrometer (Thermo
Scientific) equipped with a nanospray ion source. Peptides
were desalted on-line using a micro-Precolumn cartridge (C18
Pepmap 100, LC Packings) (with 0.5% acetic acid) and then
separated using a 320 min RP gradient (4–30% acetonitrile/
0.1% formic acid) on an Acclaim PepMap100 C18 analytical
column (3 μm, 75 μm id × 50 cm) (Dionex) with a flow rate of
0.3 μl/min. The mass spectrometer was operated in standard
data dependent acquisition mode controlled by Xcalibur 2.1.
The instrument was operated with a cycle of one MS (in the
Orbitrap) acquired at a resolution of 60,000 at m/z 400, with
the top 10 most abundant multiply-charged (2+ and higher)
ions in a given chromatographic window subjected to either
CID or ETD fragmentation in the linear ion trap with
supplemental activation enabled. An FTMS target value of
1e6 and an ion trap MSn target value of 1e4 were used.
Dynamic exclusion was enabled with a repeat duration of 45 s
with an exclusion list of 500 and exclusion duration of 30 s.
Lock mass of 445.120025 was enabled for all experiments.
Triplicate DT experiments were performed using the standard
charge and mass/charge settings in the instrument method
file. Triplicate DDNL experiments were performed when
neutral loss peaks corresponding to the loss of phosphoric
acid from precursor ions in CIDwere observedwithin the top 5
most intense CID peaks. We also performed proteome
profiling experiments (1 μg of desalted FASP digest) using
direct LC–MS/MS analyses; triplicate experiments using CID
fragmentation and triplicate DT experiments with 4-hour LC
gradients using the same LC setup and acquisition parame-
ters described above.
2.5. Data processing and database searching
All rawMSdata fileswere processed and converted intoMGF
file format using ProteomeDiscoverer 1.1 (Thermo Scientific). A
precursor filter of 600–10,000 Da and a non-fragment filter were
applied to ETD spectra to remove un-reacted precursor peaks,
charge reduced precursor peaks, neutral losses from charge
reduced precursors and FT Overtones using default settings. All
ion trap spectra with less than 15 fragmentation peaks were
removed and a signal to noise filter of 3 was applied to all
spectra. All datasets were searched using Mascot v2.2 (Matrix
Science) against a combined Human (IPI, 2010) and P. falciparum
(GeneDB) sequence database (79,637 sequences) using the
following search parameters: trypsin with a maximum of 3
missed cleavages, 10 ppm for MS mass tolerance, 0.5 Da for
MS/MS mass tolerance, with Acetyl (Protein N-term), Oxida-
tion (M), Deamidated (NQ), Carbamidomethyl (C) and
Phospho (ST) set as variable modifications. ETD spectra
were searched using c, z and y ion series and CID data was
searched using b and y ion series. All searches used Mascot's
automated decoy database searching. All data was further
analysed using Mascot Percolator V2 (http://www.sanger.ac.
uk/resources/software/mascotpercolator/) [18] to re-score
PSMs and generate final datasets with initially a q-value of
0.01 and then a posterior error probability (PEP) threshold of
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dataset with a less than 1% FDR at the PSM level. Only top
ranked hits were reported. Phosphorylation site localisation
was performed using an in-house version of SLoMo [25],
Ascore [23] and the Mascot Delta score [22]. To allow
high-throughput analysis of the data several in-house
changes were made to the original SLoMo modification site
localisation tool to generate our version of the software,
turbo-SLoMo (http://www.sanger.ac.uk/resources/software/).
SLoMowas adapted to read spectra inMGF format, and to also
generate a single combined output results summary file. New
command line options were added to allow all or a subset of
modifications (such as all phosphorylation modifications) to
be processed in a single run. Options were also added to run
the tool in a batch mode that allowed a single analysis to be
split over many computational nodes. Finally, we also added
additional filtering to exclude spectra with low Mascot
Percolator PEP scores and with large numbers of variable
modifications. Mascot delta scores were calculated as the ion
score difference between rank 1 PSMs and the next same
sequence rank ion score within the top 10 ranks reported by
Mascot. In cases where an additional same sequence rank hit
was not found, a delta score could not be calculated and
therefore was not considered a PSM with a localised phosphor-
ylation site. Delta score thresholds for CID and ETD (with
supplemental activation) equating to 1% and 5% false
localisation rates were taken from [22]. CID and ETD spectra
from DT experiments and CID spectra from DDNL experiments
were also searched with the addition of Phospho Y to identify
putative tyrosine phosphorylation sites. PSMs (PEP < 0.01) with
confidently localised tyrosine phosphorylation sites (5% FLR)
were accepted and in cases where a spectrum also matched an
alternative Phospho (ST) site then the PSM with the highest
turbo-SLoMo score was chosen and the score difference
between potential pY and pST sites included in Table S6.
Mascot dat files were converted to PRIDE XML files with PRIDE
Converter v2.0.9 and uploaded to the ProteomeXchange Con-
sortium (http://proteomecentral.proteomexchange.org) via the
PRIDE partner repository [29] with the dataset identifier
PXD000070 and DOI http://dx.doi.org/10.6019/PXD000070 and
available in the PRIDE database (http://www.ebi.ac.uk/pride/)
with accession numbers 27915-27926.3. Results and discussion
3.1. A data analysis workflow for phosphopeptide characteri-
sation using CID and ETD fragmentation
In order to obtain robust peptide identifications using
multiple fragmentation techniques, data should be processed,
database searched and scored using a single robust, global
and PSM specific FDR analysis pipeline. We have recently
adapted Mascot Percolator, a machine learning method for
rescoring database search results from ETD [18] as well as CID
data [17]. Mascot Percolator increases the number of CID PSMs
by up to 80% and ETD PSMs by up to 60% at a 0.01 q-value (1%
FDR) threshold over a standard Mascot search [18]. We
benchmarked Mascot Percolator's performance to other data-
base search and scoring algorithms for phosphopeptideidentification. Details of the extended feature set that we use
for SVMtraining in our implementationofMascot Percolator can
be found here [18]. We reanalysed published human phos-
phoproteomic data (phosphopeptides enriched from a human
cell line), which was acquired by sequential CID and ETD
analysis on an Orbitrap mass spectrometer [30], using Mascot
Percolator. 5277 and 3543 phosphopeptide PSMs (0.01 q-value
threshold)were identified for CIDandETDdatasets, respectively
(Fig. 1). This represents an increase in significant assignments of
45.5% and 53.1% compared to Mascot, 137.2% and 280.9%
compared to SEQUEST and 84.8% and 304.5% compared to X!
Tandem for CID and ETD data, respectively. The gain in
phosphopeptide identifications using Mascot Percolator for
both CID and ETD data is substantial however, the performance
of Mascot Percolator for phosphopeptide data is slightly lower
than we previously reported for data from unmodified peptides
(22) reflecting the increased complexity of spectra frommodified
peptides. Whilst we would expect improvement in the overall
performance of SEQUEST and X!Tandem when hyphenated
with percolator [31,32], it is important to note that Mascot (and
Mascot Percolator) performs significantly better than SEQUEST
and X!Tandem for analysis of ETD data, a feature that is
particularly important if CID/ETD spectral pairs are to be
analysed.
In order to assess the accuracy of Mascot Percolator for CID
and ETD phosphopeptide data, we processed data from a
human phosphopeptide library that was analysed using CID
and ETD on an Orbitrap mass spectrometer [22]. 99.2% of ETD
spectra and 99.4% of CID spectra identified byMascot Percolator
(at a 0.01 PEP threshold) were matched to the phosphopeptide
library and some additional common contaminant proteins
(e.g. BSA, keratin, and trypsin). This equates to a false discovery
rate of well below 1% which is similar to that reported for
unmodified peptides [18].
We next compared a number of phosphorylation site
localisation tools by benchmarking them using the same
phosphopeptide library dataset [22]. We began by assessing
the false localisation rate (FLR) associatedwith phosphorylation
site assignments made by Mascot (the assignment of phos-
phorylation sites in rank 1 peptides). For the 1062 CID spectra
and 685 ETD spectra (phosphoPSMs) identified at 0.01 PEP
threshold by Mascot Percolator (Fig. 2), 894 (84.73%) CID PSMs
and 624 (91.36%) of ETD PSMs identified the correct site of
phosphorylation indicating that phosphorylation sites aremore
readily localised in ETD spectra. However, in order to reach an
acceptable FLR of 5%, an increase in specificity of assignment of
10% and 5% over the standardMascot assignment is needed for
CID and ETD spectra, respectively.
Spectra corresponding to high confidence phosphopeptide
identifications (0.01 PEP threshold) were analysed using the
Mascot Delta Score, Ascore (CID only), PhosphoRS and our
modified version of SLoMo (turbo SLoMo, see Section 2.5) and
the results are summarized in Figs. 2 and S1. Initially, score
thresholds that have been reported to give a FLR of 1% were
used (Fig. S1). At a Mascot delta score threshold (ion score
difference between rank 1 and the next same sequence rank
peptide) of 11, the FLRwas 2.77% for CIDandat a score threshold
of 4; the FLR was 2.74% for ETD spectra. The Ascore probability
threshold of 0.99 gave an FLR of 1.88% for CID spectra and ETD
spectra could not be analysed. A PhosphoRS probability of 0.99
Fig. 1 – Comparison of search algorithms for identification of
phosphopeptides using CID and ETD fragmentation. Numbers
of phosphoPSMs identified using Sequest, X!Tandem, Mascot
and Mascot Percolator for a dataset of sequential CID and ETD
spectra are shown at a 1% FDR.
Fig. 2 – Comparison of phosphorylation site assignment method
Mascot delta score, Ascore, PhosphoRSand turbo-SLoMo (with a ra
was tested using a human phosphopeptide library analysed by b
each approach can be compared by looking at the proportion of i
spectra (red) to the total spectra (dark blue) and the percentage of
of 5% is indicated by a dashed red line can be compared to score th
FDR) is the most sensitive it has the highest FLR, the Mascot delt
can be seen that ETD spectra tend to give a lower false localisatio
lower score threshold for site assignment of ETD spectra (all sco
scores in turbo-SLoMo increases performance to that of the com
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1.82% for ETD spectra. Lastly, at a turbo-SLoMo score of 19, the
FLRwas found to be 2.11% for CID and 1.99% for ETD spectra. All
four tools gave a similar FLR of <5% which we regard as
acceptable for PTM localisation. However, the striking observa-
tion was that at these thresholds only a modest portion of
spectra in some cases (42.98% of CID spectra and 67.50% of ETD
spectra (Mascot Delta score), 58.91% of CID spectra (Ascore),
60.79%of CID spectra and 71.16%of ETDspectra (PhosphoRS) and
61.17% of CID spectra and 43.19% of ETD spectra (turbo-SLoMo))
were confidently localised at these thresholds which is a
considerable sacrifice in sensitivity to gain modest increases in
specificity over standard Mascot assignments. The observation
that ETD spectra are inherently more likely to identify correct
sites of phosphorylation [33] has been exploited to allow the use
of a much lower Mascot delta score threshold for ETD spectra
(delta score of 4 for 1% and 0 for 5% FLR) compared to CID data
(delta score of 11 for 1% and 4 for 5%) with comparable false
localisation rates [22] and explains the increased performance of
the Mascot delta score compared to turbo-SLoMo for ETD data.
We therefore investigatedwhether we could adjust turbo-SLoMo
score thresholds to further increase the proportion of spectra for
which we could confidently assign phosphorylation sites.s. The performance of Mascot (default rank 1 assignment),
nge of score thresholds) for phosphorylation site assignment
oth CID (A) and ETD (B) [22]. The specificity and sensitivity of
ncorrectly assigned spectra (green) and correctly assigned
those scored (light blue). The measured false localisation rate
resholds reported to give an FLR of 5%.Whilst Mascot (MP 1%
a score exhibits high specificity but low sensitivity. Overall it
n rate than CID spectra and this can be exploited by using a
red, score 2.2) by turbo-SLoMo. The use of adjusted SLoMo
mercial software PhosphoRS.
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that the FLR was maintained at <5% for CID spectra until we
reached a score threshold of 13 at which point 76.53% of the
spectra were confidently localised (Figs. 2 and 3). Repeating
the same procedure with the ETD data, we found that a much
lower threshold (score of 2.2 (all scored by turbo-SLoMo))
could be used whilst still maintaining a FLR of 5% as which
point 76.28% of spectra were confidently localised. The
relationship between the site localisation q-value (FLR) and
localisation rate is plotted in Fig. 3. It can be seen that whilst
the FLR continues to increase with decreasing score for CID
data, the FLR does not go beyond 5% for ETD data. The lowest
score that turbo-SLoMo reported was 2.2, beyond this it
reported a score of 0 indicatingmultiple top hits. Therefore, it
appears that if turbo-SLoMo assigns a score to an ETD spectrum
then the associated FLR will not exceed 5%. As this library
contains tryptic peptides with real phosphorylation sites
(they exist in nature) it is likely to be more similar to real
phosphoproteomic datasets than the degenerate phosphopep-
tide libraries that previously had been used to optimize and test
PTM localisation tools and associated false localisation rates
[25]. The use of adjusted score thresholds in turbo-SLoMo to
maximise site localisation whilst maintaining FLR rates of 5%
significantly enhances its performance to the point where it out
performs the Mascot delta score and Ascore and is comparable
in performance to the leading commercially available tool,
PhosphoRS.Fig. 3 – Calculation of adjusted SLoMo thresholds for CID and ETD
phosphorylation site assignments is plotted versus turbo-SLoMo
library. The turbo-SLoMo score at which a 5% false localisation r
significantly higher for CID than ETD data. q-Value PSM plots (C
localisation rate for turbo-SLoMo scored ETD data does not go be3.2. Large scale phosphopeptide identification using Mascot
Percolator
Next, we sought to investigate the performance of combina-
tions of CID and ETD fragmentation for analysis of complex
phosphoproteome samples. Two acquisition strategies were
employed to identify phosphopeptides from IMAC enriched
P. falciparum phosphopeptide samples. Adata dependent neutral
loss triggered ETD (DDNL) acquisition method in which every
precursor is fragmented by CID and if a characteristic neutral loss
of phosphoric acid is observed, the same precursor is also
triggered for ETD analysis. In this way, CID scans act as
‘phosphopeptide filter’ to invest more time consuming ETD
analysis on bona fide phosphopeptides. A similar approach
implemented with neutral loss triggered ECD fragmentation
was developed for phosphopeptide characterisation [34] but was
somewhat limited by the speed and sensitivity of ECD and is
therefore not suitable for phosphoproteome analysis. We com-
pared this DDNL strategy to the decision tree method developed
by Coon and co-workers [15] in which CID or ETD is used to
fragment peptides depending on precursor charge and m/z
(Fig. S2). Triplicate experiments were performed using both the
DT and DDNL strategies in which the most abundant top 10
precursor ions were subjected to CID/ETD fragmentation.
Similar numbers of fragmentation spectra were acquired for
bothmethodswith 163,820 for the DT and 159,294 for the DDNL
triplicate datasets (Tables 1, S1).data. The number of correct (blue line) and incorrect (red line)
score for CID data (A), ETD data (B) from the phosphopeptide
ate is achieved is indicated by the dashed line and is
and D (showing low q-value range)) show that the false
yond 0.05.
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standard Mascot results for over 227,000 CID spectra and over
95,000 ETD spectra from the combined set of DT and DDNL
experiments. At a 1% FDR (0.01 q-value threshold) Mascot
Percolator gave an overall 54.5% increase in CID PSMs over the
standard Mascot search (0.01 q-value threshold) with 22.6, 64.4
and 150.6% gains for 2+, 3+ and >3+ charges states respectively
(Fig. 4, Table S1). A similar gain in matched PSMs was observed
with ETD data with an overall increase of 35.9% in significant
PSMs over the standard Mascot search (0.01 q-value threshold)
with 45.6, 23.7 and 45.0% gains for 2+, 3+ and >3+ charge states,
respectively (Fig. 4 (Table S1)). We chose to use a more
conservative cut off than the usual 1% FDR (0.01 q-value
threshold) used for protein identification as we believe that
when dealing with modified peptides, PSM specific scoring
should be used to ensure high confidence at the individual PSM
level [35]. We therefore chose to use a 0.01 PEP threshold for
reporting phosphopeptide identifications, this equates to a
more conservative statistical cut-off equivalent to an overall
FDR of 0.14% [36] (Table S1). It can be seen in Fig. 4 that this
threshold results in approximately a 15% reduction in PSMs
compared to a global FDR threshold (q value) of 1%.
3.3. Combinations of CID and ETD for phosphopeptide
identification
In the DT strategy, 163,820 spectra were acquired in three
experiments (Table 1), with 45,862 CID PSMs and 18,123 ETD
PSMs identified by Mascot Percolator at a 0.01 PEP threshold
(Tables S1 & S3). In total, the DTmethod identified 3798 unique
phosphopeptide sequences (0.01 PEP threshold) with 3272
identified from CID spectra and 1361 identified from ETD
spectra (Table 2). The overlap in phosphopeptide identifications
between CID and ETD spectra using this method was 21.99%
(Table 2, Fig. S3) which is similar to that reported previously
(17.9%) for phosphopeptide analysis with this method [15].
159,294 spectra were acquired in three DNNL experiments
(Table 1), with 43,183 CID PSMs (assignment rate of 39.1%) andTable 1 – Summary of spectra acquired and results of Mascot a
Replicate 1 Replicate
A) Decision tree
CID Spectra acquired 39,904 38,227
MP PSMs (q 0.01) 17,595 17,796
MP PSMs (PEP 0.01) 15,305 15,327
Mascot (q 0.01) 10,803 11,996
ETD Spectra acquired 15,804 15,356
MP PSMs (q 0.01) 6977 6758
MP PSMs (PEP 0.01) 6156 6107
Mascot (q 0.01) 5416 5173
B) Data dependent neutral loss triggered ETD
CID Spectra acquired 36,865 37,446
MP PSMs (q 0.01) 17,191 16,627
MP PSMs (PEP 0.01) 14,918 14,291
Mascot (q 0.01) 11,374 10,561
ETD Spectra acquired 16,286 14,338
MP PSMs (q 0.01) 7367 7954
MP PSMs (PEP 0.01) 6081 6663
Mascot (q 0.01) 5314 5617
Results in bold were used to generate the final phosphoproteome datase20,140 (assignment rate of 41.1%) ETD PSMs identified by
Mascot Percolator at a 0.01 PEP threshold (Tables S1 & S2). In
total, the DDNL method identified 3808 unique phosphopep-
tide sequences (0.01 PEP threshold) with 3272 identified from
CID spectra and 2996 identified from ETD spectra (Table 2).
The overlap in phosphopeptide identifications between CID
and ETD spectra for this method was 64.5% (Table 2, Fig. S3).
71% of PSMs (0.01 PEP threshold) (CID and ETD spectra) in the
DTmethod were matched to phosphopeptides. This contrasts
with an increase in phosphoPSMs to 89% for ETD spectra in
the DDNL strategy which employs a phosphorylation selec-
tion step in the form of the neutral loss trigger. Overall, the DT
and DDNL methods identified similar numbers of unique
phosphopeptides however; given that a large proportion of
the DDNL data is composed of consecutive CID and ETD
spectra of the exact same precursor, confidence in phospho-
peptide identification by both fragmentation methods is
increased.
60% of the acquired spectra in DDNL experiments belonged
to CID/ETD spectral pairs (95,282 spectra, 47,641 pairs) (Table 2
& Fig. 5). Of these spectral pairs, 44.8% (21,341) identified the
same peptide sequence using Mascot Percolator without any
score filtering. 18,874 of these spectral pairs identified the
same phosphopeptide sequence and notably the majority
correspond to high confidence assignments; 97.5% (18,407)
had a PEP less than 0.05 and 94.3% (17,802) had a PEP less than
0.01 (Fig. 5) in at least one fragmentationmethod. Therefore, we
observe that if the same phosphopeptide sequence is identified
(no score filtering) by both CID and ETD in a spectral pair
acquired in DDNL experiments, it is almost certainly a correct
identification, equating to anoverall dataset FDRof less than 1%
without any score based filtering (0.01 q-value). This is also a
good measure of the performance of Mascot Percolator as it
confidently identified nearly all of the same phosphopeptide
sequence matching spectral pairs which are highly likely to be
real self-validating phosphopeptide identifications.
In agreement with previous reports [15], we observed that
more PSMs were identified for lower m/z and higher chargend Mascot Percolator analysis.


















Fig. 4 – Phosphopeptide spectrum match q–p plots. These q-value PSM plots display the estimated number of correct PSMs for
CID and ETD spectra from DT and DDNL experiments using Mascot, and Mascot Percolator across a range of q-value and PEP
thresholds. Plots A and B show CID and ETD datasets, respectively and plots in panel C show the estimated correct PSMs for 2+,
3+, and >3+ precursor charge states. Mascot Percolator gave 54.5% and 35.9% gains in PSMs at a 0.01 q-value (1% FDR) threshold
over the standard Mascot search for CID and ETD data, respectively.
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charge states for these phosphopeptides is higher than that
typically observed for non-modified peptides generated using
trypsin, with triply charged precursors being the most
abundant. Fig. 6A compares the numbers of PSMs assigned
from DDNL CID/ETD pairs using the best Mascot Percolator
score of each pair. Fragmentation of doubly charged
phosphopeptides gives similar numbers of best scoring PSMsby both fragmentation methods with CID performing slightly
better (13% more). However, the strong bias of ETD towards
triply charged phosphopeptides is striking with 84%more ETD
spectra from spectral pairs scoring better then CID spectra.
ETD outperformed CID for >3+ charge states mainly between
m/z of 500 and 800 whilst CID provides more confident
identifications of doubly charged precursors across most of
the m/z range and triply charged species higher than 900 m/z.
Table 2 – Comparison of CID and ETD in DT and DDNL experiments.
Replicate 1 Replicate 2 Replicate 3 Total
A) Decision tree
CID PSMs (PEP < 0.01) 15,305 15,327 15,230 45,862
PhosphoPSMs (PEP < 0.01) 10,567 10,962 10,984 32,513
% phosphoPSMs 69% 72% 72% 71%
Unique phosphopeptide sequences 2525 2610 2674 3272
ETD PSMs (PEP < 0.01) 6156 6107 5860 18,123
PhosphoPSMs (PEP < 0.01) 4396 4229 4299 12,924
% phosphoPSMs 71% 69% 73% 71%
Unique phosphopeptide sequences 1115 1087 1076 1361
CID/ETD overlap (unique phosphopeptides) 628 633 638 835
Overlap % 20.86% 20.67% 20.51% 21.99%
Total phosphoPSMs 14,963 15,191 15,283 45,437
Total unique phosphopeptides 3010 3062 3110 3798
B) DDNL
CID PSMs (PEP < 0.01) 14,918 14,291 13,974 43,183
PhosphoPSMs (PEP < 0.01) 8962 9667 9307 27,936
% phosphoPSMs 60% 68% 67% 65%
Unique phosphopeptide sequences 2342 2538 2443 3272
ETD PSMs (PEP < 0.01) 6081 6663 7396 20,140
PhosphoPSMs (PEP < 0.01) 5862 5429 6666 17,957
% phosphoPSMs 96% 81% 90% 89%
Unique phosphopeptide sequences 2061 1957 2200 2996
CID/ETD overlap (unique phosphopeptides) 1646 1611 1744 2458
Overlap % 59.70% 55.92% 60.20% 64.55%
Total phosphoPSMs 14,824 15,096 15,973 45,893
Total unique phosphopeptides 2757 2881 2897 3808
DT/DDNL overlap 3197
DT/DDNL total unique phosphopeptide sequences 4409
Overlap 72.51%
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PEP of 0.01 in either CID or ETD) is plotted in Fig. 6B and is
strongly skewed towards PSMs having better PEP scores from
ETD spectra. The median PEP for ETD PSMs was almost
two-fold smaller than that for paired CID spectra and a
significant portion of spectral pairs (29%) had a PEP of 0.01 by
only one fragmentation method (Fig. 6B, Table 3A). Therefore,
even with the superior performance of Mascot Percolator for
identification of doubly charged peptides from ETD spectra
compared to OMSSA [18] (Figs. 6, S4), there is still significant
complementarity between CID and ETD for phosphopeptide
identification and a clear utility for combinations of these
fragmentation methods for phosphoproteome analysis.
3.4. Phosphorylation site assignment using turbo-SLoMo
We analysed our P. falciparum CID and ETD datasets using
turbo-SLoMo with adjusted score thresholds to give a FLR of
5%. Of the very high confidence set (0.01 PEP threshold for
both) of 12,618 CID/ETD pairs identified in DDNL experiments,
10,902 (86.4%) phosphorylation site assignments (rank 1
assignment from Mascot Percolator) were identical for both
fragmentation methods (Table 3a). Overall, sites in 11,622
(92.1%) high confidence spectral pairs were localised using
turbo-SLoMo (FLR 5%) by either CID or ETD (Table 3b, Fig. 5).
9063 (71.8%) of these spectral pairs had the same phosphor-
ylation site assignments using turbo-SLoMo (no score cut off
applied). Strikingly, 9049/9063 (99.8%) of those spectral pairsscored by turbo-SLoMo had scores above the adjusted
thresholds (5% FLR) for at least one member of CID/ETD
spectral pairs. Therefore, if phosphorylation site assignments
from CID/ETD pairs are the same, then they are highly likely to
be correct. Thismirrors the near certainty ofmatching peptide
identifications from CID/ETD pairs that we and others [37]
have observed and highlights the utility of sequential frag-
mentation of the same precursor by different methods.
Furthermore, as almost all (99.85%) spectral pairs that were
scored by turbo-SLoMoand identified the same site,were in fact
localised with a FLR of 5% by either CID or ETD, there is little
utility in combining site localisation scores for spectral pairs to
boost site identification rates from turbo-SLoMo. Integration of
site localisation scores from spectral pairs has recently been
reported [38] and was shown to outperform A-score results
from CID or ETD data individually but not compared to
aggregate results from both CID and ETD. However, the use of
an adjusted threshold for this combined score could potentially
improve site localisation rates [38].
The remaining 2573 high confidence CID/ETD pairs did not
give the same phosphorylation site assignment at a 5% FLR by
turbo-SLoMo. Themajority of the site assignments (1900, 73.8%)
scored above threshold only in ETD members of the spectral
pairs, again reflecting the increased utility of ETD for phosphor-
ylation site assignments [33]. Crucially, only 258 CID/ETD pairs
gave confident site assignments that were on alternative
residues in the same peptide, corresponding to 2% of pairs
that were analysed using turbo-SLoMo with adjusted score
Fig. 5 – Confidence of CID and ETD spectral pair identifications
in DDNL experiments. Venn diagrams showing the breakdown
of spectral pairs in DDNL experiments; of the 47,641 spectral
pairs acquired, 21,341 (44.8%) identified the same peptide
sequence by both CID and ETD without any filtering of Mascot
Percolator scores (all PSMs irrespective of peptide confidence).
88.4% of these sequence matching pairs identified
phosphopeptides, 97.5% (18,407) of which had a PEP of 0.05 or
less and 94.3% (17,802) had a PEP of 0.01 or less. This result
indicates that if the samepeptide sequence is identified by both
CID and ETD in a spectral pair that the identification is highly
likely to be correct as assessed by Mascot Percolator. Of
12,618 high confidence spectral pairs (PEP of 0.01 in CID and
ETD, 11,622 (92.11%)) could be assigned exact sites of
phosphorylation using turbo-SLoMo (FLR 0.05).
Fig. 6 – Influence of charge state on phosphopeptide
identifications from CID and ETD spectral pairs. A: Numbers
of CID and ETD PSMs from high confidence CID/ETD spectral
pairs (both with PEP < 0.01) from DDNL experiments are
plotted to show which fragmentation method provided the
best PEP values for each charge state. ETD clearly results in
higher confidence phosphopeptide identification for 3+ and
higher charge states. B: The distribution of PEP values for
spectral pairs (PEP < 0.01 in ETD or CID) is plotted and is
colour coded by charge state. The overall distribution is
skewed towards ETD giving significantly better PEP values
than paired CID spectra.
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phosphorylation from these CID/ETD pairs with confident but
conflicting site assignments, the sites with the highest
turbo-SLoMo scores were chosen. We sought to verify if this
approach was valid by checking if any of these sites could be
confirmed by other confidently assigned/localised spectra
(turbo-SLoMo 0.05 in DT or DDNL experiments) and we found
that 237/258 of these assignments (based on the highest
turbo-SLoMo score) were validated by other spectra. Of the
remaining 21 conflicting spectral pairs for which we could not
validate the site assignment, 20 were assigned by a higher
scoringCID spectrumandoneby ahigher scoring ETDspectrum
Table 3 – (A) Phosphorylation site assignment for high confidence spectral pairs. (B): Summary of localised phosphorylation
sites in DDNL and DT strategies.
A
DDNL CID/ETD spectral pairs with matching phosphopeptide sequences
All (no PEP threshold) 18,874
PEP < 0.01 in either CID or ETD 17,802
PEP < 0.01 in both CID and ETD 12,618
Phosphorylation site matching between CID/ETD spectral pairs (PEP < 0.01 in both CID and ETD) 12,618
Default Mascot phosphorylation site assignment 10,902
No SLoMo score cut off 9063
SLoMo FLR < 0.05 9049
Breakdown of SLoMo FLR < 0.05
Site localised in both CID and ETD spectra 7334
Site localised in ETD spectrum only 1696
Site localised in CID spectrum only 19
Site match in CID and ETD (SLoMo FLR > 0.05) 14
Phosphorylation sites that do not match between CID/ETD pairs (PEP < 0.01 in both CID and ETD)
SLoMo FLR < 0.05 2573
Site localised in ETD spectrum only 1900
Site localised in CID spectrum only 415
Site localised in CID and ETD spectra (different sites) 258
Total spectral pairs with localised phosphorylation sites
(SLoMo FLR < 0.05)
11,622
B
Phospho-PSM's Site localised % site localised
SLoMo FLR < 0.05
DDNL triggered ETD
CID/ETD spectral pairsa 12,618 11,622 92.10
CID spectra only 15,321 7650 49.93
ETD spectra only 5336 4104 76.91
Totalb 45,893 34,998 76.26
Decision tree
CID spectra 32,513 17,873 54.97
ETD spectra 12,924 8344 64.56
Total 45,437 26,217 57.70
Results in italics were used to generate the final phosphoproteome datasets with an FLR of <5%.
a Spectral pairs.
b Spectral pairs counted individually.
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associated with assignments from CID spectra. The very small
number of confidently assigned (by turbo-SLoMo) sites that are
conflicting between CID and ETD spectral pairs supports the
notion that there is little gas-phase relocation of phosphate
groups in CID fragmentation [39,40].
In total, 11,622 (92.1%) high confidence CID/ETD pairs resulted
in confident phosphorylation site assignment (Table 3a). By
comparison, of 15,321 spectral pairs in which only the CID
spectrum gave a confident peptide identification (0.01 PEP
threshold), 7650 (49.9%) gave a confident phosphorylation site
assignment. Of 5336 spectral pairs in which only the ETD
spectrum gave a confident peptide identification (0.01 PEP
threshold), 4146 (76.9%) gave a confident phosphorylation site
assignment. For the DT experiments, application of adjusted
turbo-SLoMo score thresholds resulted in confident site assign-
ment of 17,873 (54.9%) CID spectra and 8334 (64.5%) ETD spectra
(Table 3b). Overall, we have shown that ETD is better forphosphorylation assignment than CID (Table 3) at 5% FLR, if
adjusted turbo-SLoMo score thresholds are used.
3.5. The P. falciparum proteome and phosphoproteome
The combined use of triplicate DT and DDNL analyses
resulted in the identification of 4409 unique phosphopeptide
sequences (mapping to 1225 unique phosphoproteins) with an
overlap in identifications of 72.5% (Fig. S3c). This is a
significant number of phosphopeptide identifications given
that the P. falciparum genome contains only approximately
5300 genes [41] and extensive phosphopeptide fractionation
was not employed. In total, 2899 unique phosphorylation sites
(0.01 PEP, 5% FLR thresholds) were localised at high confidence
(Table S4). We also performed proteome profiling experiments
from schizont digests (starting material that was used for
phosphorylation analysis) using direct LC–MS/MS analyses;
triplicate experiments using CID fragmentation and triplicate
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identified in CID-only experiments and 1770 proteins identi-
fied in DT experiments with an overlap of 1630 (82%) proteins
(Fig. S5 & Table S5).
Overall, we report identification of 2359 P. falciparum
schizont proteins (Fig. 7), almost half of the predicted proteome.
70%of proteins identified in phosphorylation experimentswere
also identified in proteome profiling experiments and an
additional 362 phosphoproteins (15% of total protein identifica-
tions) were only identified in the phosphorylation experiments,
most likely comprising proteins expressed at low levels that are
only identified after an enrichment step such as IMAC. In
addition, we observed good coverage of membrane protein
phosphorylation, 615 proteins with transmembrane domains
were identified, 49% of which we identified with phosphoryla-
tion sites, which is a good indication that efficient protein
extraction and sufficient phosphoproteome depth were
achieved (Fig. 7A). Furthermore, comparison of this dataset toFig. 7 – The Plasmodium falciparum proteome and
phosphoproteome. A: Venn diagram of the overlap of proteins
identified in proteome profiling experiments with
phosphoproteins identified in phosphoproteomic experiments.
B: The coverage of annotated subcellular locations obtained in
proteome profiling and phosphoproteomic experiments is
plotted. Notable differences were found in the mitochondrion
and the Apicoplast which appear to have lower rates of protein
phosphorylation compared to other subcellular locations.the palmitoylated complement of the P. falciparum proteome
[42] reveals that 184 proteins are both phosphorylated and
palmitoylated indicating potential dual regulation of these
proteins at membranes.
We assessed the coverage of our proteome and phos-
phoproteome data in terms of experimentally annotated
protein localisation using the ApiLoc database (Fig. 7B). The
highest coverage (identified/annotated) was observed for inner
membrane complex proteins; 95% of annotated IMC proteins
were identified in proteome profiling experiments and 67%
were identified in phosphorylation experiments. The IMC is a
complex cytoskeletal structure that plays a role in both the
development of merozoites within an infected erythrocyte and
also the invasion of new host erythrocytes after merozoites are
released. The enrichment of phosphorylation sites in IMC
proteins implies that the IMC is a dynamically regulated
organelle, with phosphorylation potentially regulating the
merozoite shape changes that accompany development and
invasion. The largest class of phosphoproteins was localised to
the nucleus (35 proteins), closely followed by cytoplasmic (32
proteins) and exported proteins (31 proteins). We found a
striking lack of phosphorylation in proteins localised to the
Apicoplast (17 proteins identified, 1/17 phosphorylated) and to
the mitochondrion (15 proteins identified, 0/15 proteins phos-
phorylated). This may be explained by the ancestral origins of
these subcellular structures, inwhich phosphorylation is not as
widespread [43,44].
Until recently [44–46], it was thought that tyrosine phos-
phorylation did not occur on plasmodium proteins because
genes coding for tyrosine kinases could not be identified in
their genomes. However, phosphoproteomic identification of
putative tyrosine phosphorylation has been validated for two
proteins [45]. We have also analysed our data to look for
tyrosine phosphorylation and we have generated a putative
list of 70 tyrosine phosphorylation sites (Table S6). Of these,
four are from contaminating human proteins (all four are
known phosphorylation sites) and another four were also
identified as being tyrosine phosphorylated in P. falciparum by
Treeck and co-workers [44]. Our set of 70 putative tyrosine
phosphorylation sites contains 18 that were identified by
multiple PSMs, and are therefore more confident and would
be a good starting point for further experimental validation.4. Conclusions
The combined use of multiple fragmentation methods for
analysis of complex peptide mixtures has been an attractive
approach to increase proteome coverage but has been limited
by appropriate data analysis pipelines to efficiently analyse
and score different data types [30,37,47]. The use of Mascot
Percolator to analyse CID and ETD spectral pairs allowed us to
perform a direct comparison of these fragmentation tech-
niques for large-scale phosphoproteomics. The overlap in
phosphopeptide identifications for high confidence CID/ETD
spectral pairs was over 70% but generally ETD produced PSMs
with significantly better PEP scores than paired CID spectra.
Although, both fragmentation methods can lead to confident
identification of the same phosphopeptide in many cases,
confident assignment of phosphorylation sites benefits from
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by ETD. The use of merged CID/ETD spectra [30] and hybrid
fragmentation techniques suchas EThcD [47,48] offers potential
routes to maximise complementarity of alternative fragmenta-
tion methods, particularly for phosphorylation site localisation
[48]. These approaches are currently limited by increased
spectral complexity and the increased number of ion series
necessary for database searching which ultimately require
increased score thresholds necessary to maintain false discov-
ery rates.
Targeted analysis of phosphopeptides by CID and ETD as
implemented in the DDNL strategy allows acquisition of spectral
pairs that self-validate both at the level of phosphopeptide
identification and phosphorylation site localisation. This extra
confidence comes without loss in sensitivity and represents a
straightforward approach for stringent phosphoproteome anal-
ysis. Importantly, data from DDNL experiments allowed us to
validate our data analysis workflow (using data from biological
samples) though using self-validation of identifications and
phosphorylation site assignments from spectral pairs. We
conclude that Mascot Percolator and turbo-SLoMo are ideally
suited for large scale analysis of protein phosphorylation using
CID and ETD fragmentation.
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